LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia

Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix

(2010) Agnieszka Siejka et al.   BJU INTERNATIONAL

GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro

(2010) Szabolcs Bellyei et al.   CANCER LETTERS

Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity

(2009) Hai-Peng Liu et al.   BJU INTERNATIONAL

Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: A genome-wide DNA microarray analysis

(2009) Mitsuhiro Tagaya et al.   CYTOKINE

Complex Mechanisms in Prostatic Inflammatory Response

(2009) Bob Djavan et al.   EUROPEAN UROLOGY SUPPLEMENTS

Benign Prostatic Hyperplasia and Its Aetiologies

(2009) Alberto Briganti et al.   EUROPEAN UROLOGY SUPPLEMENTS

Prostate growth inhibition by subtype-selective alpha1-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia

(2009) Yoshiyuki Kojima et al.   PROSTATE

Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia

(2008) Frans Debruyne et al.   EUROPEAN UROLOGY

Physical Activity, Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms

(2008) J. Kellogg Parsons et al.   EUROPEAN UROLOGY

The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study

(2008) Claus G. Roehrborn et al.   EUROPEAN UROLOGY

New Approaches to the Therapy of Various Tumors Based on Peptide Analogues

(2008) A. Schally   HORMONE AND METABOLIC RESEARCH

Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138

(2008) Elmar Heinrich et al.   PROSTATE

Growth factors in benign prostatic hyperplasia: Basic science implications

(2008) M. Scott Lucia et al.   Current Urology Reports

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

(2007) J. Curtis Nickel et al.   EUROPEAN UROLOGY